The RCVS Disciplinary Committee has agreed to accept undertakings from a Dorset veterinary surgeon, Philippa Ann Rodale MBE, in which she requests that her name is removed from the RCVS Register of Veterinary Surgeons with effect from 31 July 2015, and undertakes never to apply to be restored to it.
The Committee met on Monday 17 August, resuming a hearing which had been adjourned on 20 July. The adjournment had been made to allow Ms Rodale time to submit formal responses to the charges against her and indicate whether she agreed with them. In the event, as outlined by a letter from her solicitors received by the College on 14 August, Ms Rodale declined to comment on the charges and did not admit to any of them.
Ms Rodale did not attend the hearing on 17 August, however, the Committee decided to continue in her absence, on the understanding that, as evidenced by her solicitors’ letter, she was fully aware of the hearing and had voluntarily waived her right to be presented and represented.
The original charges related to Ms Rodale’s standards of practice (in relation to issues such as biosecurity, hygiene, in-patient facilities, drug storage and the disposal of hazardous waste, among other things) and also to a test for Intradermal Comparative Tuberculin. The charges relating to her standards of practice did not have complainants, as the College raised the matters itself; with respect to the Tuberculin test charge, the Animal and Plant Health Agency, as the relevant body, raised no objection to the proposed course of accepting undertakings.
In accepting the undertakings, the Committee felt that a contested hearing that could take up to seven days and involve up to eight witnesses for the College and up to three for the Respondent would not be in the public interest. Furthermore, since the 20 July hearing, Ms Rodale had retired and closed her practice. The Committee also noted that there had been no previous disciplinary findings against her, in what was otherwise a long and unblemished career.
Ian Green, chairing the Committee and speaking on its behalf, said: “The Committee is satisfied that the undertakings offered by the Respondent protect the welfare of animals since the Respondent has now retired and is no longer in practice. It is also satisfied that the reputation of the profession is upheld since the undertakings offered go beyond any sanction which the Committee could impose at the conclusion of a contested hearing, were any of the Heads of Charge to be found proved. It considers that it would not be proportionate or in the public interest for there to be a lengthy contested hearing.”
Vetoquinol UK has launched Marbocyl Solo – a one shot treatment for Bovine Respiratory Disease. Marbocyl Solo is a 100mg/ml solution of marbofloxacin given as one injection IM at 8mg/kg. It treats sick animals fast, killing bacteria in one go, therefore minimising lung damage and consequential morbidity. This fast action reduces the risk of the spread of infection. On top of that, Marbocyl Solo has a meat withdrawal of only 3 days (milk 3 days). “Marbocyl is a well proven antibacterial that is extensively used in cattle practice,” explains Alvin Cerely, Marbocyl’s product manager. “Marbocyl Solo is exceptionally well placed for applying ‘concentration killing’ or a‘strike action’ strategy as opposed to a ‘long action’ strategy used by other antibiotics. Marbocyl Solo is available as a separate presentation to Marbocyl 10% to avoid confusion, particularly with farmers, on different dosage regimes and withdrawal periods.”
Marbocyl Solo is available now and details have been mailed to all cattle vets in the UK and Ireland. Please contact your Vetoquinol representative or telephone 0800 169 8197 for more details.
Novartis Animal Health Inc. has completed an agreement with Luitpold Pharmaceuticals, Inc. that grants marketing rights for Adequan® Equine to Novartis in all major equine markets outside the U.S. The first launch of Adequan® Equine by Novartis will take place in Canada in June.
Adequan® Equine is indicated for treating joint dysfunction and lameness in horses caused by injury or degenerative problems. It is available for intramuscular and intra-articular administration. Adequan® is also indicated for treating joint dysfunction and lameness caused by injury or degenerative problems in dogs.
Mickey McDermott from Novartis' Communications Dept told VetSurgeon that the timing of Adequan's arrival in the UK depends on how long it takes to complete the registration transfers, but that the company hopes it'll be before the end of the year.
The requirement to treat animals entering the UK against ticks was dropped in January 2012.
Four years later, in 2016, the UK saw its first cases of Babesia canis in dogs that had not travelled abroad. MSD says it is thought the disease entered the UK carried on ticks from dogs imported from Central, Southern or Eastern Europe where the disease is rife.
Tick Awareness Month aims to highlight the need to use treatments against ticks to protect the health of pets and their owners. Vets and nurses who agree that the campaign is important are urged to write to their local parliamentary candidates explaining why introducing tick control for dogs before, during and after travel abroad is so important.
A sample letter is available on the Big Tick Project website (www.bigtickproject.co.uk).
Amanda Melvin, Marketing Manager at MSD Animal Health said: "With an election looming we want protecting UK pets and borders against non-native ticks to be on the agenda for the new Government team at DEFRA as after June 8th they start to reshape animal health policy in the UK in the build up to Brexit. If you agree that this campaign is important, during Tick Awareness Month you can get involved by writing to your local parliamentary candidates explaining why introducing tick control for dogs before, during and after travel abroad is so important."
Together, these two cancers account for almost a third of all canine cancers.
Dr. Heather Wilson-Robles, an Associate Professor at Texas A&M University and Chief Medical Officer of Volition Veterinary Diagnostics said: "The proof of concept results in these two very prevalent canine cancers give us confidence to move forward with other Nu.Q Vet assays in our pipeline, and with the larger range of cohorts and trials we have collected and planned.
"Clearly, we still have work to do as this single assay did not detect one of the other top five canine cancers, canine osteosarcoma, which was the third cancer tested in this study. However, I am delighted to see such positive results in these two significant cancers and look forward to reporting further data over the coming quarters with additional Nu.Q Vet assays, this time tested on an automated platform.”
Dr. Terry Kelly, Chief Scientific Officer of Volition America said: “It is exciting to see such strong results from our first Nu.Q Vet study conducted at Texas A&M University Veterinary Hospital. It is also interesting to note the similar patterns of detection seen in both canine and human samples confirming that the Nu.Q platform does appear to be useful in more than just human diagnostics.
"As with human diagnostics, there are currently no accurate, simple, affordable cancer screening tests available in veterinary medicine and yet 25% of dogs will develop cancer at some stage of their life. I look forward to completing the planned trials and to launch our first Nu.Q Vet product in the U.S. that we expect to occur in 2020."
Virbac has announced that it is to support the work of Glasgow student vets buy supplying their homeless project with vaccines and parasiticides.
'Trusty Paws' was set up last year by fourth year veterinary student Ruby Shorrock and a group of her fellow students to provide basic veterinary care to dogs belonging to homeless people in Glasgow.
Working with organisations which help the homeless, the students provide monthly clinics during which they give free vaccinations and flea/worm treatments to animals owned by the homeless. They also microchip them and give out bedding, food and clothing for the dogs and their owners.
Virbac is providing its Canigen DHPPi and Lepto vaccines to Trusty Paws, as well as its recently launched Milpro wormer and its Effipro spot-on flea treatment.
Royal Canin is also supplying marketing assistance to help Trusty Paws spread its good pet-care message and encourage those in need to visit the clinic. They will also provide clinical diets to those pets in need of specialised nutrition.
Ruby Shorrock: " Glasgow is in desperate need of this service as there is very little in place to help homeless people with animals - not even a dog-friendly hostel. We provide preventative care for their dogs in a friendly environment where they can also have a warm drink, a sandwich and a chat. We rely on fundraising and donations to keep the clinics running and also fundraise to help any dogs with major health problems so that they can made more comfortable for their hard life on the city's streets.
"For many homeless people, their dogs are a treasured companion. Protecting them from disease and parasites is the most important thing we can do to help them continue to benefit from this companionship.
Simon Boulton MRCVS, Head of Marketing (Companion Animal Business Unit) at Virbac, said: "In setting up Trusty Paws, Ruby and her colleagues are providing a vital service to animals in dire need of basic veterinary care. They are also extending the hand of friendship and support to homeless people in Glasgow, who already face a difficult life and value the unconditional love they get from their pet so highly. We were inspired by the fantastic work they are doing and are delighted to support them by donating our vaccines and parasite control products to them."
Last year a cohort of 1,010 veterinary surgeons responded to the CPD audit, which took place in September 2019 and included a random sample of 658 vets sourced from across all UK postcode areas.
The audit found that 820 (or 81%) of respondents met the annual requirement – a 13% increase from the 2018 audit. This followed a decline in compliance rates from 82% in 2014 to just 68% in 2018.
Amongst veterinary nurses, 79% of respondents were compliant, a 7% increase on last year’s compliance rate and the highest compliance rate ever from a veterinary nursing CPD audit.
Dr. Linda Prescott-Clements, RCVS Director of Education (pictured right), said: "It is fantastic to see that this year’s results demonstrate a significant increase in CPD compliance rates after a number of years in decline for vets and a largely static rate for veterinary nurses and I hope that it is part of a long-term trend towards the professions recognising the value of keeping their clinical and non-clinical skills up-to-date.
"This year we have made a number of changes that should make CPD compliance even easier now, including a clearer and simpler annual CPD requirement of 35 hours for vets and 15 hours for vet nurses, and the 1CPD platform and app which can be signed into through the My Account area and provides the professions with the ability to record, plan and reflect on their CPD."
Further information about the changes to the College’s CPD policy and the 1CPD platform can be found at www.rcvs.org.uk/cpd2020.
The 1CPD app can be downloaded through the Apple App Store, Google Play and via the RCVS website at https://onecpd.rcvs.org.uk/accounts/login/
Virbac has announced the reintroduction of chews as part of its dental range.
VeggieDent chews are available in packs of 15 in sizes suitable for small, medium and large dogs. The chews contain chlorhexidine and have a texture and shape designed to optimise plaque removal by physically abrading the tooth surface during chewing.
Product manager Chris Geddes said: "The gold standard of dental hygiene is regular brushing, but that isn't always possible, and products such as this are ideal for those difficult cases."
For further information please speak to your Virbac representative, phone 01359 243243 or email admin@virbac.co.uk.
Bimeda has launched Recocam, a 20mg/ml meloxicam preparation licensed for use as a single injection course in cattle, horses and pigs.
Bimeda's Head of Technical Services, Padraig Hyland MVB said: "Meloxicam's anti-inflammatory credentials and safety profile is well proven and it remains rightly popular with large animal vets. With our manufacturing expertise it makes sense to add this widely used product to our portfolio. Our aim is to provide a comprehensive range of both established standards and new innovative products for cattle and equine vets, and this is just another step in that process."
Bimeda says Recocam has a broad range of indications including acute respiratory infections, in combination with oral re-hydration in diarrhoea therapy and acute mastitis, for non-infectious locomotor disorders and lameness in pigs and alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders and pain relief associated with equine colic. In cattle Recocam can be given by single subcutaneous or intravenous injection.
Headed by Stephanie Lalor, a European Specialist in Internal Medicine, the clinic provides initial assessment and treatment - from blood work and blood pressure - to ongoing care.
Suitable for cats with a wide range of medical conditions, including respiratory tract disease, gastrointestinal conditions and endocrinopathies, the clinic is housed in Willows iCatCare certified ‘cat-friendly’ facility, which has its own cat ward and waiting area.
Stephanie, who completed a residency in Internal Medicine at Edinburgh University (funded by International Cat Care) in 2014, and then completed the Diploma of the European College of Veterinary Internal Medicine last year, said: "Here at Willows we do all we can to minimise the difficulties that cats and their owners might encounter when they come to see us.
"Our staff are trained to be aware of their needs and we have put in place not only the necessary facilities but also specific working practices in order to make any visit as stress-free as possible.
"These cat-specific clinics will be yet another string to our bow and we will work closely with referring vets to ensure that we meet each patient’s unique needs – providing a detailed written report following each visit."
For more information about the cat-specific internal medicine clinics taking place at Willows, or to make a referral, call 0121 712 7070.
For more information, visit www.willows.uk.net.
Ceva has announced that its cardiology webinar series, which attracted over 1,600 veterinary professionals when viewed live, is now available to view on-demand by visiting www.cardaliscpd.co.uk.
The webinars, which cover the management of heart failure, are presented by some of the UK's leading veterinary cardiology specialists:
Each webinar lasts for around 1.5 hours. CPD certificates are then available after answering questions relating to each webinar.
For further information visit www.cardaliscpd.co.uk.
Dechra Veterinary Products has published a new series of video presentations about the diagnosis and treatment of canine hypoadrenocorticism to help veterinary surgeons who are prescribing Zycortal for the condition.
The six videos, which were recorded by Dechra's technical team, range in length from 10 minutes to 37 minutes.
Episode one describes the pathophysiology of Addison’s disease, different types of Addison’s disease and helps veterinary surgeons recognise the common clinical presentations of chronic hypoadrenocorticism.
Episode two examines the similarities in clinical presentation between hypoadrenocorticism and other disease processes.
The third episode looks at the changes commonly seen in the haematology, biochemistry and urinalysis of Addison’s patients. This section also covers how to perform and interpret hormone testing with the knowledge of the common causes of false positive results.
The fourth looks at a clinical presentation of an acute Addisonian crisis and best practice for emergency treatment of these patients, as well as the transfer of an acute patient onto maintenance treatment with Zycortal.
The final two films explore the treatment and monitoring of a patient on Zycortal and how to switch existing Addisonian patients from fludrocortisone acetate to Zycortal. It also documents the help which is available for those more complex cases.
Dechra Brand Manager Craig Sankey said: "These short films are an important support tool for any veterinary professional who is treating patients with hypoadrenocorticism or who may be presented with cases in their practice.
"Addison’s disease can be very hard to diagnose as it mimics so many other illnesses and we hope these presentations will give insights into a complex disease. The introduction of Zycortal has been a vital development in the treatment of the disease and we hope the new resources will be beneficial to veterinary professionals."
The presentations complement resources that Dechra has already produced for dog owners, including a website -www.myaddisonsdog.co.uk - which provides information and resources to help dog owners understand the condition and monitor their pet's progress.
Visitors will be given a behind-the-scenes look and have the opportunity to chat with Specialist surgeons Andy Moores and Chris Jordan.
Andy said: “We have had a fantastic first six months, and to say thank you to those who have referred cases to us, and to show off our facilities to those who haven’t seen the clinic, we are thrilled to be holding an open evening.
"I’m looking forward to providing tours of the clinic and having a chance to talk to vets about our services and how we can help.”
All veterinary professionals and their families, and pet owners are welcome.
The clinic is situated just off the M3 and 30 minutes from the M25, in the village of Upton Grey, near Basingstoke.
To register your interest and book a place at the open day please contact Marie at Marie@mooresortho.com or 01256 632100.
The RCVS Charitable Trust has made two 'Blue Sky' grants of £20,000 each for research into feline rotavirus and equine gut bacteria.
One award has been made to Allison German and Kenton Morgan at the University of Liverpool as a Richard Daubney Research Fellowship. This will enable research to be undertaken into the molecular epidemiology and zoonotic potential of feline rotavirus in UK cats.
Allison said: "Feline rotaviruses have been identified in diarrhoeic children in Japan, Italy, Israel and America, but because of limited funding options, there has been no systematic study of rotaviruses in cats, so the prevalence, risk factors and zoonotic potential are unknown. I am pleased that the Trust has recognised the importance of emerging infectious diseases in companion animals and their potential role in animal and human health."
By assessing faecal samples from cats within Cats Protection Adoption Centres in the UK, the study aims to discover the prevalence of rotavirus in this cat population and broadly identify the strains of feline rotavirus that are circulating, including looking for any with identity to human strains. The study will also determine whether the molecular epidemiology of rotavirus in the cat population enables understanding of the diversification and evolution of rotaviruses in people.
A second Blue Sky award of £20,000 has been made to Chris Proudman and Alistair Darby, also at the University of Liverpool, to research the role of gut bacteria in horse health and disease. Called Metagenomic Analytical Utilities for Equines (MANURE), the project will sequence DNA from microbes taken from horse intestines, and analyse the diversity, composition and abundance of the microbial populations. This is expected to improve veterinary understanding of the role of equine gut bacteria, and benefit horses and their owners. Tools being developed to characterise and investigate equine gut microbiota, and findings expected, such as the discovery of novel bacteria, should also be useful to other research.
RCVS Trust Director Cherry Bushell said: "As usual, the standard of applications was very good, although we do continue to receive a relatively high number of applications for projects that the assessors judge to be more 'surveys' than genuine blue sky research.
"In deciding which research to fund, a number of factors are taken into account, such as the quality and strength of the research team, the likelihood of success, and whether a genuine gap in knowledge has been identified. For example, the feline rotavirus research could have important findings in the longer term if it is found that there is genuine risk to human health, and also shows clear potential for further study. Similarly, the equine gut bacteria study is likely to increase considerably knowledge over the longer term and to attract funding from elsewhere for further research."
The University of Bristol's Langford Veterinary Services (LVS) has announced the completion of its new clinical facilities.
The first phase of the £13 million development includes a new small animal surgery building, comprising five theatres, an ICU, a dedicated anaesthesia induction and recovery and an imaging suite.
The imaging suite comprises a 16-slice CT scanner, for small animals and horses, conventional digital radiography with a DR system, a high-resolution fluoroscopy, diagnostic ultrasound, echocardiography, scintigraphy and a high resolution 1.5 tesla MRI scanner available seven days a week.
Lynne Hill, Chief Executive of LVS, said: "The new facility provides state-of-the art diagnostic imaging facilities at all times, to help the animals under our care."
LVS highlights the case of Gainsborough, an eight-year-old Irish draught gelding, to illustrate the benefits of its new facilities. The horse, used for jumping and endurance, was initially presented to the Equine Hospital in October 2010, with clinical signs including nasal airflow obstruction and discharge, which was limiting his athletic capabilities.
Using videoendoscopy and radiography, a space-occupying mass was diagnosed in the paranasal sinuses impinging into the nasal cavity. With the horse conscious, but sedated, using regional local anaesthetic nerve blocks, the bulk of the mass was removed and he returned to work. However, the owner reported a recurrence of the clinical signs and he was returned to the clinic for reassessment.
The new imaging suite, only one of a few such units in the UK, has been adapted to enable the imaging of a horse's head while conscious using a frictionless air plinth. The adaptation allows detailed imaging of both bone and soft tissue structures within a horse's head, without requiring a general anaesthetic.
Using the new imaging suite, Gainsborough's CT examination revealed a portion of the mass, which had been inaccessible to the previous keyhole surgery, had expanded into the nasal cavity. The detail of the images enabled careful planning of a second operation that facilitated removal of the large remnant of the mass, which appeared to be benign, with minimal collateral trauma.
In addition to imaging the heads of conscious horses, dogs and cats are able to undergo complete body scans using the same unit while anaesthetised. As well as enabling detection and diagnosis of lesions without invasive or painful tests at an earlier stage, the unit will facilitate operative planning and add to the body of knowledge of disease pathogenesis.
For more information about LVS, visit: http://www.langfordvets.co.uk/
The Royal Veterinary College is calling for dogs diagnosed with osteoarthritis to take part in a revolutionary study in which their movement will be monitored by a state-of-the-art recorder.
The recorder (pictured right), which is attached to the dog's collar, uses miniaturised sensors based on those found in smart phones. It can distinguish between different activities independent of the dog's location, allowing constant recording of movement in the dog's home environment, to complement the traditional clinical assessments carried out as part of the trial.
The study is being carried out to assess the efficacy of the joint mobility supplement Yumove in reducing the clinical signs of osteoarthritis. This will be the first time that the real effect of a joint supplement has been measured.
Dr. John Howie, co-founder of Lintbells, the company that makes Yumove, said: "This is the first time the real effect of a joint supplement has been measured and it will be a very fast trial. Yumove is a supplement that has been specifically formulated to include glucosamine, chondroitin and Omega 3 from green-lipped mussel, which all work together to increase joint mobility and provide an anti-inflammatory effect."
The research is being led by Dr Matthew Pead the RVC's Academic Director of Professional Assessment and Development. He said: "The results of this study will have important clinical implications for the understanding and treatment of canine OA, with the ultimate aim of advancing the treatment of this difficult and degenerative disease for the benefit of many thousands of dogs."
Any veterinary surgeon with a patient in their practice that might benefit from this study is invited to refer them. Further details are available the Clinical Investigation Centre at the Royal Veterinary College - email cic@rvc.ac.uk or phone 01707 666605.
MSD says the campaign will help veterinary nurses and front-of-house staff start the conversation about parasite control by asking clients about their pets' favourite hiding places, where parasites are often found. The supporting campaign tools and materials are designed to help practice staff then uncover pet owner needs to ensure they get the best recommendation.
Amanda Melvin, Marketing Manager at MSD Animal Health said: "Vet nurses and front-of-house staff are usually the first contact pet owners have with the practice. Yet the potential they have to add value to the whole consultation process is often underestimated.
"Our ‘No Hiding’ campaign has been designed to make use of this expertise by helping them find a way of sharing their knowledge. When it comes to pet owners this is usually best achieved by sharing those conversations about the unusual quirks and habits of their pets. That way they can uncover their hiding places and give them the best advice on parasite control."
The ‘No Hiding’ campaign offers a range of resources for practices including in-practice training, social media support, and interactive waiting room resources - demonstrating the practice’s expertise and allowing pet owners to share in the unique hiding habits of their pets.
For further information, contact your MSD Animal Health account manager.
Mary (or, to give her her full title, Dr Mary Fraser BVMS PhD CertVD PGCHE FHEA MAcadMEd CBiol FRSB FRSPH FRCVS) focussed on decision-making in practice while studying for her MRes in Clinical Veterinary Research, looking at how vets and owners influence the decision making process. This led her to consider how decision making is taught to students.
As part of the initiative, Mary has launched a new website: www.clinicaldecisions.org, which, together with a supporting blog, is designed to help students and recent graduates examine their decision making in practice, consider how owners influence it, and take forward shared decision making for the benefit of all.
Mary said: "As a student decision making can seem difficult. Working with owners, all of whom have different expectations, can add to those challenges.
"I hope that by bringing that discussion to the fore we can support each other and allow future vets and veterinary nurses to identify their own strengths in supporting owners to make the best decisions for their animals."
Find out more and contribute to the discussion at www.clinicaldecisions.org
The extension will triple the size of the hospital's waiting room and nearly double the number of consultation rooms to seven, including one cat-only consult room and a cat-only waiting area.
The work to improve facilities for felines will also enable NWVS to apply for the International Society of Feline Medicine (ISFM) gold award.
Clinical director Prue Neath said: “This work will serve to further enhance the modern facilities we have on offer and add to our wide range of cutting-edge equipment which is all aimed at delivering the very best of care and treatments to our pet patients.
“We are always looking to expand our expert team and recruit new specialists, clinicians and vet nurses, as well as extending our in-house opportunities for residents and interns to fulfil their veterinary ambitions.
“This work will be another piece in the jigsaw which allows us to meet those ambitions, both in terms of the care we deliver to pets and the opportunities we offer to outstanding clinicians.”
www.nwspecialists.com
Photo: Sarah Hardy, client services team leader at NorthWest Veterinary Specialists
The session will be conducted in the style of the BBC Radio 4 Moral Maze discussion programme, with panelists and witnesses arguing for and against the viewpoint corporatisation is inevitable and will benefit vets and their clients.
Moderated by Madeleine Campbell, Keith Chandler and Karl Holliman will argue for corporatisation and Andrew Harrison and Tim Greet will be against. They will call upon a series of 'witnesses' for detailed questioning before the topic is more broadly debated.
CVS, the UK’s biggest veterinary group now owns more than 410 veterinary practices, of which over 30 are specifically equine or mixed practices.
The latest equine acquisitions include Bell Equine, a one-site Equine Referral Hospital in Kent, in January 2017 and Severn Edge Veterinary Group, a mixed practice with 12 sites in Shropshire, including a six-vet dedicated equine practice, in April 2017.
One line of argument says that the commercial and business advantages of a corporate, together with their scale and diversity, can give veterinary surgeons greater potential for a more flexible career path and advancement within the industry, and a more sustainable working career in equine practice.
On the flip side, there's the removal of any opportunity to buy into ownership, reduced decision-making ability because of adherence to corporate procedures, extra paperwork, longer approval processes and an increased emphasis on the bottom line.
David Mountford, Chief Executive of BEVA said: "The auditorium is usually full to bursting for our Moral Maze sessions because they bring a broader and more engaging dimension to important topics. The statement Corporatisation of equine practices is inevitable and will benefit vets and their clients is bound to generate some stimulating and possibly heated debate."
This year's BEVA Congress will be held at Liverpool Arena Convention Centre, and anyone who registers before 3rd August will receive significantly reduced booking fees.
For more information, visit: www.beva.org.uk.
The range comprises of a detangling pre-wash, a cleansing shampoo and a fragrant conditioner, all of which are pH balanced and formulated using natural ingredients and a blend of essential oils designed to make bathtime a calmer experience.
The products all come in 300ml bottles with a list price of £6; RRP £12.
The Pet Remedy range can be ordered direct from Animalcare on 01904 487687 (orders@animalcare.co.uk) or from your veterinary wholesaler.
The event offers over 80 hours of CPD across seven streams – with everything from hypotension and sepsis to breaking bad news to clients – as well as world-renowned speakers and networking opportunities.
Søren Boysen from the University of Calgary in Canada and Sophie Adamantos from Paragon Referrals in Wakefield, are among several high-profile speakers at this year’s Congress.
Chief Executive for GB Snowsport, Victoria Gosling OBE, will open Congress as keynote speaker where she’ll focus on perseverance, resilience and teamwork.
Also speaking are Prof. John Williams, Richard Casey, executive director at the World Small Animal Veterinary Association and VDS trainer Elly Russell.
Arlene Connor, an RVN and head of clinical operations at Vets Now and IVC Evidensia has planned the programme alongside national ECC lead Dan Lewis (pictured right).
She said: “We’re so excited to be returning to the Royal Armouries for our 19th Vets Now ECC Congress – around a theme which celebrates us all being together again.
"The past two years have been a challenge for all of us in the veterinary professions and we hope to mitigate that with a return to face-to-face learning and networking, as well as the chance to have some fun.
"Events like this can be hugely inspirational — for the organisers as well as the attendees — and we truly can’t wait to welcome everyone through the doors like old times.”
Dan added: “There’s a brilliant line-up of live speakers, workshops, a packed exhibition hall and more opportunities than ever for delegates to meet old friends and make new ones, as well as to learn from some of the world’s leading veterinary experts discussing emergency and critical care.
“Our programme again this year has been carefully tailored to provide an inclusive learning experience for vets and vet nurses no matter what stage they’re at in their career, from students through to specialists.
Tickets range in price from £45 + VAT for exhibition-only tickets, up to £470 + VAT for a vet to attend for 2 days plus the Gala dinner.
To book your ticket, go to www.vets-now.com/congress2022
Guidelines on the examination of rams for breeding have now been officially updated, thanks to the pooled expertise of delegates at a recent Sheep Fertility Workshop, sponsored by Ceva Animal Health, the Sheep Veterinary Society and EBLEX-AHDB.The previous Sheep Veterinary Society guidelines on the examination of rams for breeding were drawn up in 2007. However, the society says that to date, there has been considerable variation in the practice of ram fertility testing amongst sheep vets across the country.
The Sheep Fertility Workshop, which was held in Edinburgh in June 1014, brought together veterinary experts and scientists to discuss the provision of a comprehensive, evidence-based, best practice protocol, with clear recommendations for practitioners on the assessment of rams.Dr Fiona Lovatt, senior vice president of the Sheep Veterinary Society and director of Flock Health Ltd, who coordinated the workshop, said: "The outcome of some active debating was the recognition that various elements of the guidelines needed to be updated in line with currently recognised best practice. One thing that is really essential is that the practising vet is clear as to the reason for the ram PBE and carefully considers how to communicate the findings and their limitations to the ram's owner."
The updated guidelines cover three levels of ram pre-breeding examinations (PBE):
Carol Atkinson, Ceva's reprodAction range marketing manager, said: "We are proud to have supported the workshop, the outcome of which has been some valuable modifications to the guidelines. We now have a robust, practical benchmarking system in place to help ensure consistency of ram fertility and flock health and development."
The workshop was funded by the Sheep Veterinary Society, Ceva Animal Health and EBLEX-AHDB, with contributions in kind from Innovis, Zoetis and Novartis Animal Health.
The guidelines are available to all members of the Sheep Veterinary Society and can be downloaded from www.sheepvetsoc.org.uk, together with two further forms that are available following appropriate training: SVS Ram PBE data collection and SVS Ram certificate. The Sheep Veterinary Society will be holding a series of CPD days for practitioners in advance of next year's breeding season. Further details will be posted on the website shortly.